FDA Approved: RAXIBACUMAB — Supplemental Application (Emergent Manufacturing Operations Baltimore LLC)

View source ↗

Summary

FDA approved a supplemental application for manufacturing operations of RAXIBACUMAB (raxibacumab) by Emergent Manufacturing Operations Baltimore LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax
• Inhalational Anthrax

Drugs mentioned

• Raxibacumab (raxibacumab)

Snippet

SUPPL AP for RAXIBACUMAB (RAXIBACUMAB)